133 related articles for article (PubMed ID: 24630047)
21. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
[TBL] [Abstract][Full Text] [Related]
22. Chronic valproate or levetiracetam treatment does not influence cytokine levels in humans.
Guenther S; Bauer S; Hagge M; Knake S; Olmes DG; Tackenberg B; Rosenow F; Hamer HM
Seizure; 2014 Sep; 23(8):666-9. PubMed ID: 24880639
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
[TBL] [Abstract][Full Text] [Related]
24. Levetiracetam.
Krishna K; Raut AL; Gohel KH; Dave P
J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
[TBL] [Abstract][Full Text] [Related]
25. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
26. The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy.
Cho YW; Kim DH; Motamedi GK
Seizure; 2011 May; 20(4):336-9. PubMed ID: 21316267
[TBL] [Abstract][Full Text] [Related]
27. Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy.
Contin M; Mohamed S; Albani F; Riva R; Baruzzi A
Epilepsy Res; 2012 Feb; 98(2-3):130-4. PubMed ID: 21944894
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of levetiracetam in children with epilepsy.
Li J; Xiao N; Chen S
Brain Dev; 2011 Feb; 33(2):145-51. PubMed ID: 20359839
[TBL] [Abstract][Full Text] [Related]
29. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
Cho JR; Koo DL; Joo EY; Yoon SM; Ju E; Lee J; Kim DY; Hong SB
Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706
[TBL] [Abstract][Full Text] [Related]
30. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
Lee GH; Kim BM; Kang JK; Lee SA
Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
[TBL] [Abstract][Full Text] [Related]
31. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Kim DW; Lee SY; Shon YM; Kim JH
Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
[TBL] [Abstract][Full Text] [Related]
32. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam monotherapy for late poststroke seizures in the elderly.
Kutlu G; Gomceli YB; Unal Y; Inan LE
Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
[TBL] [Abstract][Full Text] [Related]
35. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
[TBL] [Abstract][Full Text] [Related]
37. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
De Smedt T; Raedt R; Vonck K; Boon P
CNS Drug Rev; 2007; 13(1):57-78. PubMed ID: 17461890
[TBL] [Abstract][Full Text] [Related]
38. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.
Alsaadi TM; Shatzel A; Marquez AV; Jorgensen J; Farias S
Seizure; 2005 Mar; 14(2):139-42. PubMed ID: 15694569
[TBL] [Abstract][Full Text] [Related]
39. Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study).
Borggraefe I; Bonfert M; Bast T; Neubauer BA; Schotten KJ; Maßmann K; Noachtar S; Tuxhorn I; May TW; Heinen F;
Eur J Paediatr Neurol; 2013 Sep; 17(5):507-14. PubMed ID: 23642492
[TBL] [Abstract][Full Text] [Related]
40. New onset paediatric epilepsy in 1-5 years age group children--approach to management in a tertiary care centre with newer anti-epileptic levetiracetam.
Barik KL; Paul UK; Bhattacharyya AK; Adhikary A; Agarwal G; Rana KS
J Indian Med Assoc; 2014 Feb; 112(2):100-2. PubMed ID: 25935964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
